Literature DB >> 17509507

Tear evaporation rates in Sjögren syndrome and non-Sjögren dry eye patients.

Eiki Goto1, Yukihiro Matsumoto, Mizuka Kamoi, Koji Endo, Reiko Ishida, Murat Dogru, Minako Kaido, Takashi Kojima, Kazuo Tsubota.   

Abstract

PURPOSE: To reinvestigate tear evaporation rates in Sjögren syndrome (SS) and non-Sjögren (non-SS) dry eye patients with a recently reported ventilated chamber evaporimeter system.
DESIGN: Prospective case-control study.
METHODS: A ventilated chamber evaporimeter system was used to measure tear evaporation rates. A DR-1 camera (Kowa, Nagoya, Japan) was used for tear lipid layer interference image acquisition. The Yokoi severity grading system was used for DR-1 image evaluation. Twenty-four aqueous tear deficiency (ATD) eyes of 21 consecutive patients with SS were studied (SS ATD group). Twenty-one ATD eyes of 12 non-SS patients (non-SS ATD group) were examined as control subjects.
RESULTS: Tear evaporation rates of the SS ATD group (5.9 +/- 3.5 [10(-7) g/cm(2) per second]) were significantly higher than those of the non-SS ATD group (2.9 +/- 1.8 [10(-7) g/cm(2) per second]; P = .0009). The severity grading of DR-1 tear interference images of the SS ATD group was significantly higher (P = .03), along with significantly worse meibomian gland expressibility and vital staining scores, compared with those of the non-SS ATD group.
CONCLUSIONS: Tear evaporation rates were higher in eyes of the SS ATD group compared with the non-SS ATD group. Tear evaporation assessed in conjunction with tear lipid layer findings and meibomian gland expressibility provides an increased understanding in the differential diagnosis of dry eye states.

Entities:  

Mesh:

Year:  2007        PMID: 17509507     DOI: 10.1016/j.ajo.2007.03.055

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  26 in total

1.  The use of fluorescent quenching in studying the contribution of evaporation to tear thinning.

Authors:  Jason J Nichols; P Ewen King-Smith; Erich A Hinel; Miru Thangavelu; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-20       Impact factor: 4.799

Review 2.  The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee.

Authors:  Alan Tomlinson; Anthony J Bron; Donald R Korb; Shiro Amano; Jerry R Paugh; E Ian Pearce; Richard Yee; Norihiko Yokoi; Reiko Arita; Murat Dogru
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 3.  The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.

Authors:  Debra A Schaumberg; Jason J Nichols; Eric B Papas; Louis Tong; Miki Uchino; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

4.  Comparison of corneal biomechanics in Sjögren's syndrome and non-Sjögren's syndrome dry eyes by Scheimpflug based device.

Authors:  Qin Long; Jing-Yi Wang; Dong Xu; Ying Li
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

5.  Ocular manifestation of rheumatoid arthritis-different forms and frequency.

Authors:  Gordana Zlatanović; Dragan Veselinović; Sonja Cekić; Maja Zivković; Jasmina Dorđević-Jocić; Marko Zlatanović
Journal:  Bosn J Basic Med Sci       Date:  2010-11       Impact factor: 3.363

6.  Meibomian gland atrophy with duration of Sjogren's syndrome in adult females.

Authors:  Sung Rae Noh; Jae Lim Chung; Jeong Min Lee; Kyoung Yul Seo; Kyungmin Koh
Journal:  Int Ophthalmol       Date:  2021-08-19       Impact factor: 2.031

7.  Manifestation of meibomian gland dysfunction in patients with Sjögren's syndrome, non-Sjögren's dry eye, and non-dry eye controls.

Authors:  Yeon Soo Kang; Hyo Seok Lee; Ying Li; Won Choi; Kyung Chul Yoon
Journal:  Int Ophthalmol       Date:  2017-05-31       Impact factor: 2.031

8.  Epidemiology of Meibomian Gland Dysfunction in an Elderly Population.

Authors:  Yousef A Alghamdi; Carolina Mercado; Allison L McClellan; Hatim Batawi; Carol L Karp; Anat Galor
Journal:  Cornea       Date:  2016-06       Impact factor: 2.651

9.  Meibomian gland dropout in Sjögren's syndrome and non-Sjögren's dry eye patients.

Authors:  Siwen Zang; Ying Cui; Yang Cui; Wenlei Fei
Journal:  Eye (Lond)       Date:  2018-06-22       Impact factor: 3.775

10.  Long-Term Outcome of Treatment with Topical Corticosteroids for Severe Dry Eye Associated with Sjögren's Syndrome.

Authors:  Hyun Ho Jung; Yong Sok Ji; Mi Sun Sung; Kyung Keun Kim; Kyung Chul Yoon
Journal:  Chonnam Med J       Date:  2015-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.